GCK基因拷贝数变异在青少年起病的成人型糖尿病中的识别
该研究对疑似MODY但靶向NGS致病变异检测阴性的患者,使用CNV caller工具(VarSeq v1.4.3)重新分析,发现两名无关联患者携带GCK外显子1的杂合全外显子缺失(4763 bp),并经全外显子组测序和Sanger测序确认,家系分析显示该缺失与疾病共分离。结论提示在靶向NGS中常规纳入CNV分析可提高MODY诊断率。
要点
- 对疑似MODY且靶向NGS变异检测阴性者,应重新分析GCK拷贝数变异。
- CNV caller工具可从靶向NGS数据中检出GCK大片段缺失,无需额外测序。
- GCK外显子1杂合缺失在两家系中与MODY表型共分离,可能为致病原因。
核心结论
- 应用CNV caller工具从NGS数据中筛查GCK拷贝数变异具有实用性。
- GCK外显子1缺失可能是MODY的致病原因。
- 在靶向NGS评估MODY时常规纳入CNV分析可能提高诊断率并减少假阴性。
研究设计与样本
- 对疑似MODY但靶向NGS致病性变异检测阴性的患者,使用CNV caller工具(VarSeq v1.4.3)重新分析。
- 发现两名患者可能携带GCK外显子1杂合全外显子缺失后,用全外显子组测序和Sanger测序确认并确定精确断点。
- 对两名先证者的患病与未患病一级亲属进行家系样本分析。
主要发现
- 两名临床表现符合MODY且看似无关联的患者中,检出影响GCK整个外显子1的4763 bp杂合全外显子缺失。
- 该缺失在患病与未患病家系成员中跨代共分离一致。
临床怎么用
- 对疑似MODY但靶向NGS未检出致病变异者,可重新分析GCK拷贝数变异。
- 在靶向NGS评估MODY时,可考虑常规纳入CNV分析以提高诊断率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Next generation sequencing (NGS) methods to diagnose maturity-onset diabetes of the young (MODY), a monogenic autosomal dominant cause of diabetes, do not typically detect large-scale copy number variations (CNVs). New techniques may allow assessment for CNVs using output data from targeted NGS, without requiring additional sequencing. Using this technique, two kindreds of patients presenting with features of MODY were found to bear the same heterozygous large-scale deletion in GCK. METHODS: Patients suspected of having MODY but with negative targeted NGS pathogenic variant calling were reanalyzed using the CNV caller tool (VarSeq v1.4.3). Two patients were identified as having a possible heterozygous whole exon deletion affecting exon 1 of GCK. For confirmation and determination of the exact breakpoints, whole exome sequencing followed by Sanger sequencing were used. Familial samples from both affected and nonaffected first-degree relatives were then analyzed for each proband. RESULTS: A heterozygous whole-exon deletion spanning 4763 bp affecting the entire exon 1 of GCK was detected in two apparently unrelated patients with clinical features of MODY. This deletion showed segregation concordance across generations in affected and nonaffected family members. CONCLUSIONS: Our findings confirm the utility of applying the CNV caller tool to screen for CNVs in GCK from NGS data. In so doing, we identified a deletion of exon 1 of GCK as likely causal for MODY. Our data indicate that incorporating CNV analysis routinely when assessing for MODY via targeted NGS may increase diagnostic yield and reduce false negative genetic testing rates.
引用
- Berberich AJ, Huot C, Cao H, et al. Copy Number Variation in GCK in Patients With Maturity-Onset Diabetes of the Young. J Clin Endocrinol Metab. 2019. PMID: 30912798. doi:10.1210/jc.2018-02574
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。